Ask AI

From Podium to Practice: Experts Discuss Their Current and Future Management of RCC

Gain a deeper understanding of how to optimize first-line and subsequent-line treatments for renal cell carcinoma (RCC), including targeted and immunotherapy-based regimens, based on the latest practice-changing data and expert recommendations through downloadable slides.

Share

Program Content

Activities

Emerging Data and Management of Renal Cell Carcinoma
Emerging Data and Management of Renal Cell Carcinoma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 17, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AVEO Pharmaceuticals, Inc. and Eisai.

AVEO Pharmaceuticals, Inc.

Eisai